4.5 Review

Cobalt derivatives as promising therapeutic agents

Journal

CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 17, Issue 2, Pages 189-196

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2012.11.019

Keywords

-

Funding

  1. National Science Foundation
  2. Center for Cancer Nanotechnology Excellence (CCNE) initiative of the National Institutes of Health's National Cancer Institute [U54CA151880]

Ask authors/readers for more resources

Inorganic complexes are versatile platforms for the development of potent and selective pharmaceutical agents. Cobalt possesses a diverse array of properties that can be manipulated to yield promising drug candidates. Investigations into the mechanism of cobalt therapeutic agents can provide valuable insight into the physicochemical properties that can be harnessed for drug development. This review presents examples of bioactive cobalt complexes with special attention to their mechanisms of action. Specifically, cobalt complexes that elicit biological effects through protein inhibition, modification of drug activity, and bioreductive activation are discussed. Insights gained from these examples reveal features of cobalt that can be rationally tuned to produce therapeutics with high specificity and improved efficacy for the biomolecule or pathway of interest.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available